- Global Pharma News & Resources

Global Lung Cancer Therapeutics Market Predicted To Rise At A Lucrative CAGR Throughout 2020 To 2027

DBMR has added a new report titled Global Wearable Medical Devices Market with data Tables for historical and forecast years represented with Charts & Graphs spread through Pages with easy to understand detailed analysis. This also Report has also been compiled to provide various market aspects such as size, share, trends, dynamics, growth, sales, and industry analysis. The competitive analysis taken place in this report include strategic profiling of key market players, their core competencies, their strong and weak points, and the competitive landscape of the market which supports businesses illustrate their individual strategies.

Lung cancer is a type of cancer that reduces the efficacy of the lungs to supply the bloodstream with oxygen.  The main factors which are responsible for the lung cancer are cigar smoking, asbestos exposure, cigarette smoking, and other. As per the size which can be checked with the microscope, these cancers can be differentiated. Some of the common symptoms of lung cancer are headache, bone pain, shortness of breath, chest pain, coughing up blood, and hoarseness. According to doctor, lung cancer usually damages the cells that line the lungs. Lung cancers are of two types non- small cell lung cancer, and small cell lung cancer. These cancers can be treated by various therapies such as radiation therapy, chemotherapy, vaccines, and immunotherapies.

Get More Insights, Grab Free Sample PDF @

Some of the factors responsible for the growth of Lung Cancer Therapeutics Market:

  • Increasing cases of lung cancer: There is tremendous increase in the cases of lung cancer worldwide. Every year around 1.6 million deaths are caused due to cancer. Lung cancer is commonly caused by smoking, asbestos, radon and other pollutants. There are certain contaminants present at home and at work that can raise the cancer risk such as asbestos, arsenic, diesel exhaust, and certain sources of silica and chromium. This is the factor due to which non- smokers also get cancer. This is the factor due to which there is increase in the demand for lung cancer treatment worldwide
  • Growing number of smokers: Smoking is considered as the major factor which causes lung cancer. About 5 million deaths a year are caused by smoking-related disease. They have the ability to cause small cell and non- small cell cancer. Increasing number of cigarettes the person smoke each day also increases the risk of cancer. This is another factor which increases the risk of cancer and enhances the demand for cancer treatment

By Geography:

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

This Free report sample includes:

  • A brief introduction to the research report.
  • Graphical introduction of the regional analysis.
  • Top players in the market with their revenue analysis.
  • Selected illustrations of market insights and trends.

Some of the launches and acquisition in the Lung Cancer Therapeutics Market are:

  • In June 2019, Biodesix, Inc announced the acquisition of Oncimmune’s laboratory and incidental pulmonary nodule (IPN) malignancy test. The extensive experience and patent portfolio of Oncimmune in autoantibodies and their relationship with cancer has inspired the company to consider the use of Oncimmune’s EarlyCDT Lung test as a strategic extension to our U.S. diagnostic test package. This acquisition will help the company to enhance their portfolio and strengthen their market position
  • In February 2019, AdoRx Therapeutics announced that they will partner with Johnson & Johnson so they can create lung cancer treatments. The new collaboration aims at developing treatments using the fit-for-use antagonists of AdoRx receptors. They are designed to modulate the effects of high levels of adenosine seen in the tumor microenvironment, which allows the immune system to evade cancer

For More Insights Get FREE Detailed TOC @

Global lung cancer therapeutics market is segmented into seven notable segments which are cancer type, molecule type, drug class, treatment type, therapy type, end user, distribution channel.

  • On the basis of cancer type, the market is segmented into non-small cell lung cancer, metastatic lung cancer, mesothelioma, chest wall tumors, pulmonary neuroendocrine tumors, mediastinal tumors
    • In March 2019, FDA approved the Roche’s Tecentriq in combination with the chemotherapy for initially treating adults with an extensive stage of small cell lung cancer. This would help company to enhance its customer base.
  • On the basis of molecule type, the market is segmented into small molecules, biologics.
    • In January 2019, Bristol-Myers Squibb is entered into an agreement to acquire Celgene (U.S.). With this acquisition Bristol-Myers Squibb is able to create a premier innovative biopharma company which will increase the company’s product line for the lung cancer therapeutics market.

Leading Key Players:

Some of the prominent players operating in this market are Takeda Pharmaceutical Company Limited, ONO PHARMACEUTICAL CO., LTD., F. Hoffmann-La Roche Ltd, Novartis AG, Eli Lilly and Company., AstraZeneca, Boehringer Ingelheim International GmbH, Merck & Co., Inc., CELGENE CORPORATION, AMGEN INC., Sanofi, Johnson & Johnson Services, Inc., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., ALLERGAN, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, GlaxoSmithKline plc., Astellas Pharma Inc., Sumitomo Dainippon Pharma Co., Ltd., and many others.

Why Choose DBMR?

  • Regional demand estimation and forecast
  • Pre-commodity pricing volatility
  • Technological updates analysis
  • Location Quotients Analysis
  • Raw Material Sourcing Strategy
  • Competitive Analysis
  • Product Mix Matrix
  • Vendor Management 

Access Full Report Directly With Discounted Price @

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 17-Mar-2021